Famed short-seller Chanos can't cash in on Valeant
Jim Chanos: I'm still short Valeant and not about to quit
Exclusive: SEC probe of Valeant began with review of short seller - sources | Reuters
What the Average Short Position in Valeant
The 'Short' Who Sank Valeant Stock - WSJ
Here's how much Valeant short sellers have been killing it ever since Bill Ackman got in the stock
Short seller Citron backs off Valeant claims - MassDevice
Citron Research Report Is Out
What Valeant's fall from grace can teach the drug industry
Valeant shares plunge after 'fraud' accusation from short-seller | CBC News
Valeant's Epic 90% Plunge: A Timeline of How it Happened | Fortune
Q&A with Safkhet's Fahmi Quadir: 'I love investigating frauds and making money at their expense'' - Financial News
Short Seller Famous for Bet Against Valeant Targets Tesla - YouTube
The Valeant Meltdown and Wall Street's Major Drug Problem | Vanity Fair
Valeant 'short' smells smoke — even when there's no fire
File:Valeant Pharmaceuticals' Business Model (26683524705) (cropped).jpg - Wikimedia Commons
Netflix's 'Dirty Money' Exposes the Corporate Corruption Running the World | GQ
Hacked Printers. Fake Emails. Questionable Friends. Fahmi Quadir Was Up 24% Last Year, But It Came at a Price. | Institutional Investor
Hacked Printers. Fake Emails. Questionable Friends. Fahmi Quadir Was Up 24% Last Year, But It Came at a Price. | Institutional Investor
Valeant Short Seller Dials Back Warning of Bombshell Report on Monday - WSJ
Valeant's response to controversy is 'nonsense,' says short seller | Fortune
Valeant: Yes, Ackman's a Loser. But How Much Did Short Sellers Make? | Barron's
Netflix Dirty Money — An Interview With Erin Lee Carr
Valeant shares recoup losses after company rejects short seller report - MarketWatch
